Artificial Retina Market Revenue & Market Analysis, 2026-2035

The global artificial retina market was evaluated at USD 1,179.71 million in 2025 and is expected to expand at a CAGR of 24.1% from USD 1,444.20 million in 2026 to USD 10,058.57 million in 2035. The robust market expansion is fueled by increasing demand for vision-recovery options for patients with severe retinal degenerative conditions, especially retinitis pigmentosa and advanced age-related macular degeneration. Improvements in retinal implants, photovoltaic devices, microelectronics, wireless energy transfer, and dense electrode arrays are enhancing the prospects of artificial vision technologies.

Published: September 2, 2026
100 Pages

Market Overview

According to the National Eye Institute (NEI), age-related macular degeneration (AMD) is a leading cause of vision loss among older adults in the United States, creating a growing need for advanced technologies that can restore or improve visual function. The increasing prevalence of retinal degenerative disorders, rapidly aging population, rising investment in retinal prostheses and bionic vision technologies, and advancements in bioelectronic and implantable retinal devices are driving the growth of the U.S. artificial retina market.

The global artificial retina market has recorded gradual historical growth, supported by the rising prevalence of retinal degenerative disorders, increasing demand for vision-restoration technologies, and continued advancements in retinal prostheses and implantable ophthalmic devices. Improvements in electrode design, implant miniaturization, wireless power delivery, and visual signal processing have also contributed to the development of increasingly sophisticated artificial vision systems. For instance, in 2022, Pixium Vision reported continued clinical progress with its PRIMA photovoltaic retinal implant, supporting the development of subretinal technology for patients with severe retinal vision loss.

The global artificial retina market is expected to witness strong growth during the forecast period, driven by increasing investment in artificial vision research, expansion of clinical trials, technological improvements in photovoltaic and electronic retinal implants, and growing interest in solutions for patients with irreversible vision loss. The transition of next-generation retinal prostheses from experimental research toward broader clinical evaluation is expected to create additional opportunities for market expansion. For instance, in 2025, Science Corporation continued clinical development of its PRIMA-based photovoltaic retinal implant, highlighting the growing focus on advanced subretinal technologies to restore functional vision.

Artificial Retina Market Overview

Base Year Market Size (2025): USD 1,179.71 Million

CAGR: 24.1%

Forecast Year Market Size (2035): USD 10,058.57 Million

Leading Region: North America

Emerging Countries: China, India, Brazil, South Korea, South Africa

Major Players:

  • Science Corporation

  • Second Sight Medical Products

  • Pixium Vision

  • Nano Retina

  • Bionic Vision Technologies (BVT)

Artificial Retina Market Trends

The artificial retina market is witnessing notable advancements, driven by the growing shift toward subretinal photovoltaic implants, increasing focus on functional vision restoration, improvements in implant resolution, and the transition of retinal prostheses from experimental technologies toward early commercialisation.

· Subretinal implants are gaining attention because they can stimulate surviving retinal cells more directly while enabling wireless operation through externally projected near-infrared light.

· Developers are increasingly targeting useful visual functions such as reading and recognizing objects rather than only basic light perception. Clinical results from PRIMA have strengthened interest in this approach.

· Artificial-retina development is increasingly extending beyond retinitis pigmentosa toward geographic atrophy associated with age-related macular degeneration, Stargardt disease, and other inherited retinal disorders.

· Wireless and light-powered architectures are gaining preference because they can reduce the need for internal wiring and potentially simplify implant construction while reducing mechanical burden on ocular tissues.

Collectively, the transition to photovoltaic subretinal implants, enhanced resolution stimulation, advanced image processing, expanded disease applications, wireless systems, and initial commercialisation are significant trends influencing the global artificial retina market.

Artificial Retina Market Analysis

By Product Type

Subretinal implants dominate the global artificial retina market due to their ability to stimulate surviving retinal cells more directly and their strong potential for higher-resolution functional vision restoration.

Based on product type, the global artificial retina market is categorized into epiretinal implants, subretinal implants, and suprachoroidal implants. The subretinal implants segment holds the largest market share of 76.67% in 2025.

By Disease Indication

Retinitis pigmentosa dominates the global artificial retina market due to its long-standing role as the primary target indication for retinal prostheses and the significant unmet need for vision restoration among patients with advanced disease.

Based on disease indication, the global artificial retina market is categorized into retinitis pigmentosa, dry age-related macular degeneration (geographic atrophy), Stargardt disease, and other inherited retinal dystrophies (IRD). The retinitis pigmentosa segment holds the largest market share in 2025.

By End-use

Hospitals dominate the global artificial retina market due to their advanced ophthalmic infrastructure, specialized retinal surgeons, and ability to provide comprehensive implantation and postoperative care.

Based on end-use, the global artificial retina market is categorized into hospitals, specialty eye clinics, and others. The hospitals segment holds the largest market share in 2025.

Regional Analysis

North America dominates the global artificial retina market due to its advanced ophthalmic infrastructure, strong clinical research ecosystem, early adoption of retinal technologies, and presence of leading artificial-vision developers.

The North America artificial retina market holds the leading regional position with the largest share of 41.34% in 2025.

Europe is emerging as a key growth region in the artificial retina market, supported by strong ophthalmology research capabilities, specialized retinal centers, and increasing clinical adoption of advanced vision-restoration technologies.

The Europe artificial retina market is gaining momentum as the region expands clinical evaluation and commercialization of next-generation retinal implants. Strong research networks, government-supported ophthalmic innovation, specialist surgical expertise, and recent regulatory progress for photovoltaic retinal implants are creating a favorable environment for market development. Germany, France, and the UK are particularly important markets due to their established retinal-care and clinical research infrastructure.

Key Companies Profiled

The global artificial retina market is characterized by an innovation-driven and evolving competitive landscape, with specialized retinal-prosthesis developers, neurotechnology companies, and ophthalmic device manufacturers competing through implant technology, clinical evidence, regulatory progress, and technological differentiation. Leading companies are focusing on improving implant resolution, wireless power delivery, biocompatibility, and functional vision restoration.

Science Corporation, Cortigent (Vivani Medical), Nano Retina, Bionic Vision Technologies, and NIDEK are among the prominent companies participating in the artificial retina and broader artificial-vision landscape. Competition is increasingly centered on subretinal photovoltaic implants, microelectrode arrays, wireless retinal prostheses, and advanced visual-signal processing. The competitive environment is also being shaped by clinical trials, regulatory approvals, strategic collaborations, and commercialization efforts. For instance, Science Corporation's PRIMA platform has advanced toward commercialization following European regulatory approval, strengthening the competitive position of photovoltaic subretinal technology. At the same time, the market remains relatively specialized, with high R&D requirements, complex surgical procedures, lengthy regulatory pathways, and limited manufacturing capabilities creating barriers to entry. These factors favor companies with strong intellectual property, clinical-development capabilities, specialized surgical networks, and access to substantial funding.

Artificial Retina Market Companies:

  • Altris, Inc.

  • Axorus SAS

  • Bionic Vision Technologies

  • Bionic Sight, LLC

  • Carl Zeiss Meditec AG

  • Cortigent (Vivani Medical, Inc.)

  • iBIONICS

  • LambdaVision, Inc.

  • Monash Vision Group

  • Nano Retina Ltd.

  • NIDEK CO., LTD.

  • Optobionics Corporation

  • Pixium Vision S.A.

  • Retina Implant AG

  • Science Corporation

  • Second Sight Medical Products, Inc.

  • VisionCare Ophthalmic Technologies, Inc.

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the artificial retina market by-

Product Type (Revenue in USD Million, 2021 - 2035)

  • Epiretinal Implants

  • Subretinal Implants

  • Suprachoroidal Implants

Disease Indication (Revenue in USD Million, 2021 - 2035)

  • Retinitis Pigmentosa

  • Dry Age-Related Macular Degeneration (Geographic Atrophy)

  • Stargardt disease

  • Other Inherited Retinal Dystrophies (IRD)

End-use (Revenue in USD Million, 2021 – 2035)

  • Hospitals

  • Specialty Eye Clinics

  • Others

Regional (Revenue in USD Million, 2021 - 2035)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

    • Switzerland

    • Netherlands

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

    • Indonesia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Epiretinal Implants

4.2. Subretinal Implants

4.3. Suprachoroidal Implants

5. Market Estimates and Forecasts, By Disease Indication, 2021 – 2035 (USD Mn)

5.1. Retinitis Pigmentosa

5.2. Dry Age-Related Macular Degeneration (Geographic Atrophy)

5.3. Stargardt disease

5.4. Other Inherited Retinal Dystrophies (IRD)

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Specialty Eye Clinics

6.3. Others

7. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

7.1. North America

7.1.1. U.S.

7.1.1.1. U.S. Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

7.1.2. Canada

7.1.2.1. Canada Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.1.2.2. Market Dynamics

7.1.2.3. Competitive Landscape

7.1.2.4. Regulatory Framework

7.1.2.5. Reimbursement Scenario

7.2. Europe

7.2.1. Germany

7.2.1.1. Germany Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.1.2. Market Dynamics

7.2.1.3. Competitive Landscape

7.2.1.4. Regulatory Framework

7.2.1.5. Reimbursement Scenario

7.2.2.

7.2.3. U.K.

7.2.3.1. UK Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.3.2. Market Dynamics

7.2.3.3. Competitive Landscape

7.2.3.4. Regulatory Framework

7.2.3.5. Reimbursement Scenario

7.2.4. France

7.2.4.1. France Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.4.2. Market Dynamics

7.2.4.3. Competitive Landscape

7.2.4.4. Regulatory Framework

7.2.4.5. Reimbursement Scenario

7.2.5. Italy

7.2.5.1. Italy Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.5.2. Market Dynamics

7.2.5.3. Competitive Landscape

7.2.5.4. Regulatory Framework

7.2.5.5. Reimbursement Scenario

7.2.6. Spain

7.2.6.1. Spain Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.6.2. Market Dynamics

7.2.6.3. Competitive Landscape

7.2.6.4. Regulatory Framework

7.2.6.5. Reimbursement Scenario

7.2.7. Sweden

7.2.7.1. Sweden Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.7.2. Market Dynamics

7.2.7.3. Competitive Landscape

7.2.7.4. Regulatory Framework

7.2.7.5. Reimbursement Scenario

7.2.8. Norway

7.2.8.1. Norway Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.8.2. Market Dynamics

7.2.8.3. Competitive Landscape

7.2.8.4. Regulatory Framework

7.2.8.5. Reimbursement Scenario

7.2.9. Denmark

7.2.9.1. Denmark Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.9.2. Market Dynamics

7.2.9.3. Competitive Landscape

7.2.9.4. Regulatory Framework

7.2.9.5. Reimbursement Scenario

7.2.10. Switzerland

7.2.10.1. Switzerland Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.10.2. Market Dynamics

7.2.10.3. Competitive Landscape

7.2.10.4. Regulatory Framework

7.2.10.5. Reimbursement Scenario

7.2.11. Netherlands

7.2.11.1. Netherlands Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.11.2. Market Dynamics

7.2.11.3. Competitive Landscape

7.2.11.4. Regulatory Framework

7.2.11.5. Reimbursement Scenario

7.2.12. Rest of Europe

7.2.12.1. Rest of Europe Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.2.12.2. Market Dynamics

7.2.12.3. Competitive Landscape

7.2.12.4. Regulatory Framework

7.2.12.5. Reimbursement Scenario

7.3. Asia Pacific

7.3.1. China

7.3.1.1. China Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.1.2. Market Dynamics

7.3.1.3. Competitive Landscape

7.3.1.4. Regulatory Framework

7.3.1.5. Reimbursement Scenario

7.3.2. Japan

7.3.2.1. Japan Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.2.2. Market Dynamics

7.3.2.3. Competitive Landscape

7.3.2.4. Regulatory Framework

7.3.2.5. Reimbursement Scenario

7.3.3. India

7.3.3.1. India Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.3.2. Market Dynamics

7.3.3.3. Competitive Landscape

7.3.3.4. Regulatory Framework

7.3.3.5. Reimbursement Scenario

7.3.4. Australia

7.3.4.1. Australia Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.4.2. Market Dynamics

7.3.4.3. Competitive Landscape

7.3.4.4. Regulatory Framework

7.3.4.5. Reimbursement Scenario

7.3.5. South Korea

7.3.5.1. South Korea Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.5.2. Market Dynamics

7.3.5.3. Competitive Landscape

7.3.5.4. Regulatory Framework

7.3.5.5. Reimbursement Scenario

7.3.6. Thailand

7.3.6.1. Thailand Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.6.2. Market Dynamics

7.3.6.3. Competitive Landscape

7.3.6.4. Regulatory Framework

7.3.6.5. Reimbursement Scenario

7.3.7. Indonesia

7.3.7.1. Indonesia Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.7.2. Market Dynamics

7.3.7.3. Competitive Landscape

7.3.7.4. Regulatory Framework

7.3.7.5. Reimbursement Scenario

7.3.8. Rest of Asia Pacific

7.3.8.1. Rest of Asia Pacific Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.3.8.2. Market Dynamics

7.3.8.3. Competitive Landscape

7.3.8.4. Regulatory Framework

7.3.8.5. Reimbursement Scenario

7.4. Latin America

7.4.1. Brazil

7.4.1.1. Brazil Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.4.1.2. Market Dynamics

7.4.1.3. Competitive Landscape

7.4.1.4. Regulatory Framework

7.4.1.5. Reimbursement Scenario

7.4.2. Mexico

7.4.2.1. Mexico Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.4.2.2. Market Dynamics

7.4.2.3. Competitive Landscape

7.4.2.4. Regulatory Framework

7.4.2.5. Reimbursement Scenario

7.4.3. Argentina

7.4.3.1. Argentina Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.4.3.2. Market Dynamics

7.4.3.3. Competitive Landscape

7.4.3.4. Regulatory Framework

7.4.3.5. Reimbursement Scenario

7.4.4. Colombia

7.4.4.1. Colombia Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.4.4.2. Market Dynamics

7.4.4.3. Competitive Landscape

7.4.4.4. Regulatory Framework

7.4.4.5. Reimbursement Scenario

7.5. Middle East and Africa

7.5.1. South Africa

7.5.1.1. South Africa Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.5.1.2. Market Dynamics

7.5.1.3. Competitive Landscape

7.5.1.4. Regulatory Framework

7.5.1.5. Reimbursement Scenario

7.5.2. Saudi Arabia

7.5.2.1. Saudi Arabia Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.5.2.2. Market Dynamics

7.5.2.3. Competitive Landscape

7.5.2.4. Regulatory Framework

7.5.2.5. Reimbursement Scenario

7.5.3. UAE

7.5.3.1. UAE Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.5.3.2. Market Dynamics

7.5.3.3. Competitive Landscape

7.5.3.4. Regulatory Framework

7.5.3.5. Reimbursement Scenario

7.5.4. Kuwait

7.5.4.1. Kuwait Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.5.4.2. Market Dynamics

7.5.4.3. Competitive Landscape

7.5.4.4. Regulatory Framework

7.5.4.5. Reimbursement Scenario

7.5.5. Rest of Middle East and Africa

7.5.5.1. Rest of MEA Artificial Retina Market Estimates and Forecasts to 2035 (USD Mn)

7.5.5.2. Market Dynamics

7.5.5.3. Competitive Landscape

7.5.5.4. Regulatory Framework

7.5.5.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. Altris, Inc.

8.5.2. Axorus SAS

8.5.3. Bionic Vision Technologies

8.5.4. Bionic Sight, LLC

8.5.5. Carl Zeiss Meditec AG

8.5.6. Cortigent (Vivani Medical, Inc.)

8.5.7. iBIONICS

8.5.8. LambdaVision, Inc.

8.5.9. Monash Vision Group

8.5.10. Nano Retina Ltd.

8.5.11. NIDEK CO., LTD.

8.5.12. Optobionics Corporation

8.5.13. Pixium Vision S.A.

8.5.14. Retina Implant AG

8.5.15. Science Corporation

8.5.16. Second Sight Medical Products, Inc.

8.5.17. VisionCare Ophthalmic Technologies, Inc.

9. Analyst Perspective

10. Related Reports

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.